Related Experiment Videos
[Changes of thyroid hormone levels in the progression of coronary arteriosclerosis]
Insights
Thyroid hormone levels in ischemic heart disease patients change with disease severity. Before myocardial infarction, T4 to T3 conversion is inhibited; after infarction, hormone levels decrease, reflecting metabolic changes.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Research
Background:
- Ischemic heart disease (IHD) impacts cardiovascular and metabolic functions.
- Thyroid hormones (TH), including thyroxine (T4) and triiodothyronine (T3), play a crucial role in regulating metabolism.
- The relationship between IHD severity and thyroid hormone dynamics is not fully understood.
Purpose of the Study:
- To investigate changes in thyroid hormone (T3, T4) levels and their ratios in patients with ischemic heart disease (IHD).
- To correlate these hormonal changes with the severity of coronary atherosclerosis, myocardial insufficiency, and clinical symptoms.
- To compare thyroid hormone profiles with hemodynamic and metabolic parameters of the myocardium.
Main Methods:
- Serum levels of T3 and T4 were measured in patients with varying degrees of IHD, including incipient angina pectoris (IAP), acute myocardial infarction (AMI), and postinfarction myocardial dysfunction (PIMD).
- Coronary atherosclerosis severity was assessed using coronaroangiography.
- Thyroid hormone levels were analyzed in relation to hemodynamic and myocardial metabolic parameters.
Main Results:
- Thyroid hormone concentrations were found to be dependent on coronary circulation efficiency and myocardial metabolism.
- In IHD patients before myocardial infarction (MI), thyroid hormone levels were stable, with inhibited conversion of T4 to T3.
- Following MI and development of postinfarction myocardial dysfunction (PIMD), both T4 and T3 levels decreased below control levels, indicating altered myocardial metabolic processes.
- In cases of intact myocardial function, the T4/T3 ratio was elevated due to high serum T4.
- During acute coronary syndrome, T3 levels dropped while T4 levels increased, attributed to suppressed deiodination.
Conclusions:
- Thyroid hormone levels and their interconversion are significantly altered in patients with ischemic heart disease.
- These alterations correlate with the severity of coronary atherosclerosis and myocardial dysfunction.
- Changes in thyroid hormone metabolism reflect the intensity and pattern of metabolic processes within the myocardium during IHD progression and post-MI recovery.
Abstract:
The study concerned changes in the levels of thyroid hormones (T3, T4) and their proportional relations in the serum of peripheral venous blood of patients with ischemic heart disease (IHD) with reference to severity of coronary and myocardial insufficiency and clinical symptoms. Thyroid hormones (TH) were examined in patients with stenosing atherosclerosis of the coronary arteries with incipient angina pectoris (IAP), acute myocardial infarction (AMI), chronic IHD before and after MI and postinfarction myocardial dysfunction (PIMD) depending on severity of coronary atherosclerosis. The findings were compared to hemodynamic and metabolic myocardial parameters, severity of coronary atherosclerosis assessed at coronaroangiography. It is shown that TH concentrations depend on efficiency of coronary circulation and characteristics of myocardial metabolism. IHD patients have isometric TH levels before MI, conversion of T4 into T3 being inhibited. After MI and development of PIMD at the compensation stage T4 and T3 levels lowered under control levels. This reflects intensity and pattern of metabolic processes in the myocardium. In intact myocardial function T4/T3 in the above patients was above the control levels because of high concentration of serum T4. In development of acute coronary syndrome the level of T3 fell while that of T4 went up due to suppression of its deiodination.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypothyroidism II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction